###begin article-title 0
###xml 43 45 43 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Regulatory role of E-NTPase/E-NTPDase in Ca2+/Mg2+ transport via gated channel
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
E-NTPase/E-NTPDase is activated by millimolar concentrations of Ca2+ or Mg2+ with a pH optimum of 7.5 for the hydrolysis of extracellular NTP and NDP. It has been generally accepted that E-NTPase/E-NTPDase plays regulatory role in purinergic signalling, but other functions may yet be discovered.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 134 136 134 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
In this article it is proposed on the basis of published data that E-NTPase/E-NTPDase could play a role in the influx and efflux of Ca2+and Mg2+ in vivo.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 44 47 <span type="species:ncbi:10116">rat</span>
Attenuation of extracellular Ca2+ influx by rat cardiac sarcoplasmic anti-E-NTPase antibodies and oligomerization studies on mammalian CD39 conclusively point towards the existence of a new channel in the membrane. Further studies on these properties of the E-NTPase/E-NTPDase may provide detailed mechanisms and identify the potential patho-physiological significance.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 29 31 29 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 302 305 302 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 505 508 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 518 522 518 522 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(i) </bold>
###xml 563 567 563 567 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ii) </bold>
###xml 600 603 600 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 656 659 656 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 664 667 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 769 772 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 777 780 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
The mechanism by which [Ca2+]i is increased in excitable cells differs from that obtaining in non-excitable cells. Excitable cells exhibit an action potential, a substantial general depolarization of the plasma membrane, in response to depolarizing stimuli; influx of Ca2+ occurs via plasma membrane Ca2+ channels and/or release from sarco (endo) plasmic reticulum via ryanodine-receptor Ca2+ channels which regulate the excitation - contraction coupling [1,2]. The factors that determine the extent of Ca2+ entry are (i) magnitude of the membrane potential and (ii) magnitude of the transmembrane Ca2+ gradient. These two factors also determine whether Ca2+ or Mg2+ enters and the time (probably milliseconds) that elapses between channel opening and termination of Ca2+ or Mg2+ transport [3].
###end p 9
###begin p 10
###xml 43 45 43 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 46 48 46 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 154 157 154 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 237 238 237 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 258 260 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
In non-excitable cells, the increase in [Ca2+]i results from influx of Ca2+ across the plasma membrane and Ca2+ release from the endoplasmic reticulum. Ca2+ release from the SER depends on the binding of inositol 1,4,5-triphosphate (InsP3) to its receptor Ca2+channels, and also on Ca2+ binding to ryanodine receptor - Ca2+channels.
###end p 10
###begin p 11
###xml 2 5 2 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 54 57 54 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i: </bold>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 203 205 203 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 208 212 208 212 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ii: </bold>
###xml 234 237 234 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 273 276 273 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 327 329 327 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 332 337 332 337 <bold xmlns:xlink="http://www.w3.org/1999/xlink">iii: </bold>
###xml 353 355 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 370 373 370 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 404 407 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 449 451 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 453 457 453 457 <bold xmlns:xlink="http://www.w3.org/1999/xlink">iv: </bold>
###xml 463 464 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 467 470 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 504 506 504 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 602 605 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 656 657 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 668 671 668 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Ca2+ is removed from the cell by the following means. i: the sarco (endo) plasmic reticular Ca2+ pump ATPase (SERCA), which transports Ca2+ from the cytoplasm into the SER lumen (~70% of the activator Ca2+); ii: The plasma membrane Ca2+ pump ATPase (PMCA), which exports Ca2+ across the plasma membrane (~1% of the activator Ca2+); iii: Mitochondrial Ca2+Uniporters (mCa2+ uniporters), which transport Ca2+ into mitochondria (~1% of the activator Ca2+);iv: the Na+/Ca2+ exchanger (28% of the activator Ca2+). This last transport system is reversible but under normal physiological conditions, in the Ca2+ extrusion mode, it exhibits a stoichiometry of 3 Na+influx/1 Ca2+ efflux [4].
###end p 11
###begin p 12
###xml 2 5 2 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 29 33 29 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(i) </bold>
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 63 71 63 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(VOCC), </bold>
###xml 72 76 72 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ii) </bold>
###xml 118 127 118 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(LGCCS), </bold>
###xml 132 137 132 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink">iii) </bold>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 191 198 191 198 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(RACC) </bold>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 240 247 240 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(ROCC) </bold>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 655 656 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 657 658 657 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 788 790 788 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 791 792 791 792 <sub xmlns:xlink="http://www.w3.org/1999/xlink">I</sub>
###xml 812 814 812 814 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 815 816 815 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 879 880 879 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
Ca2+ enters animal cells via (i) voltage-operated Ca2+channels (VOCC), (ii) ligand gated non-specific cation channels (LGCCS), and (iii) stretch/receptor activated non-specific Ca2+ channels (RACC) [4,5]. A "receptor operated Ca2+ channel" (ROCC) is defined as a plasma membrane Ca2+ channel other than VOCC or RACC. VOCC opening depends on membrane depolarization, whereas RACC opening depends on both direct and indirect activation of membrane bound receptors. In contrast, ROCC opening depends solely on agonist-receptor interaction. It has also been suggested that mobile intracellular messengers such as elevated [Ca2+]i play a role in ROCC opening [5,6]. Different types of ROCC are activated (opened) by diverse cell signaling mechanisms such as ligand specificity, increase in [Ca2+]I, increase in [cAMP]i [7] and activation/inactivation of specific trimeric G proteins [8].
###end p 12
###begin p 13
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 401 404 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Opening of Ca2+ channels must be a highly regulated event involving physical movement of channel components inclusive of the alteration in channel protein conformation; Also, an extracellular source of free energy (DeltaG) could be of critical importance. This might be supplied by E-NTPase/E-NTPDase mediated hydrolysis of NTP/NDP. Co-ordination of this process might play a role in the opening of Ca2+ channels, independently of membrane depolarization or other factors.
###end p 13
###begin p 14
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 160 162 160 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ii</bold>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 191 194 191 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink">iii</bold>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 211 213 211 213 <bold xmlns:xlink="http://www.w3.org/1999/xlink">iv</bold>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 243 244 243 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink">v</bold>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
The biochemical, structural, and functional properties of E-type nucleotidases have been covered in several excellent reviews: i. Extracellular metabolism [9]; ii. purine signalling [10,11]; iii. adhesion [12]; iv. transporter functions [13]; v. pathophysiology [14,15].
###end p 14
###begin title 15
###xml 69 71 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Rationale for the proposed hypothesis: E-NTPase/E-NTPDase mediated Ca2+/Mg2+ transport
###end title 15
###begin p 16
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 443 445 443 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 449 451 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 455 458 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 464 467 464 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 484 487 484 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 643 646 643 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
It has been suggested that Ca2+ entry during the slow inward current in normal myocardium involves membrane-bound channels potentially controlled and/or regulated by metabolic energy transfer from unknown sources, though Ca2+ enters the cell down its concentration gradient [16]. Electrical stimulation and membrane phosphorylation by cAMP-dependent protein kinase have been shown to increase E-NTPase/E-NTPDase activity. Metal ions such as Mn2+, Co2+, Ni2+ and La2+ that attenuate Ca2+ influx also inhibit the E-NTPase. In the late stages of heart failure the E-NTPase is down regulated. Activation of E-NTPase by various concentrations of Ca2+ has been shown to correlate linearly with cardiac contractile force development [17].
###end p 16
###begin p 17
###xml 0 18 0 18 <bold xmlns:xlink="http://www.w3.org/1999/xlink">"Calcium paradox" </bold>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 178 180 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 309 312 309 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 333 336 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 392 394 392 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 475 478 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 543 546 543 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 602 605 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
"Calcium paradox" is defined as irreversible functional and structural protein loss in the isolated heart that is first perfused with Ca2+-free buffer and then reperfused with Ca2+-containing buffer [18]. E-NTPase activity is highest during the initial phases of reperfusion, which might favour the initial Ca2+ influx that causes Ca2+ overload. During the later stages of reperfusion with Ca2+-containing buffer there is a loss of E-NTPase activity. During mild stages of Ca2+ paradox, E-NTPase retains its function and continues to favour Ca2+ influx, resulting in the development of intracellular Ca2+ overloads. However, during severe stages of calcium paradox, impaired E-NTPase activity may contribute to irreversible failure of contractile force recovery [19].
###end p 17
###begin p 18
###xml 125 127 125 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 130 133 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 221 223 221 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
To date there is no report describing the detailed mechanism of E-NTPase/E-NTPDase-mediated channel gating and its role in Ca2+/Mg2+ transport. In this article an attempt is made to delineate the molecular mechanism of Ca2+/Mg2+ transport, identifying the source of energy and the activation and termination of the process. The central issues are:
###end p 18
###begin p 19
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
a. How the metabolic energy from nucleotide hydrolysis is effectively utilized in channel opening;
###end p 19
###begin p 20
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
b. What stage of the opening/closing cycle requires energy;
###end p 20
###begin p 21
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
c. By what (probable) mechanism the proposed scheme is completed;
###end p 21
###begin p 22
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
d. How, if at all, homeostasis is affected
###end p 22
###begin p 23
The current hypothetical proposal is set out in three sections with appropriate illustrations.
###end p 23
###begin title 24
Phase I: Activation
###end title 24
###begin p 25
identifies the evidence that leads to the current proposal and describes how the metabolic energy from nucleotide triphosphate hydrolysis is utilised to assemble a functional homo-oligomer of the E-NTPase/E-NTPDase, forming a channel that is subsequently opened.
###end p 25
###begin title 26
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 28 30 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Phase II: Suggested: Ca2+/Mg2+Transport
###end title 26
###begin p 27
Describes, with supporting evidence, how the energy released from [NTP] o/ [NDP] o hydrolysis might be utilized for opening the channel formed by the homo-oligomeric ENTPase/E-NTPDase.
###end p 27
###begin title 28
Phase III: Termination of the transport processes
###end title 28
###begin p 29
###xml 99 101 99 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
outlines the intracellular and extracellular factors that would influence the termination of the Ca2+/Mg2+ transport processes, and the experimental evidence obtained in favor of the whole proposal.
###end p 29
###begin title 30
Phase I: Activation of E-NTPase/E-NTPDase and channel formation
###end title 30
###begin p 31
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 457 459 457 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 462 465 462 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 606 608 606 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 611 614 611 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 633 634 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
Membrane depolarization could locally alter protein conformation. This in turn could potentially induce post-translational modification in the (intracellular) monomer subunits of the E-NTPase/E-NTPDase, followed by translocation to the membrane (depending on the tissue type(s) and functional requirement(s)) (Fig. 1). Fig. 2 shows the proposed functional state of the E-NTPase/E-NTPDase after oligomerization and assembly in the membrane to form a gated Ca2+/Mg2+ channel. Fig. 3, indicates that the oligomerized E-NTPase/E-NTPDase is likely to possess sensors to control the opening and closing of the Ca2+/Mg2+ channel gate. Fig. 4, represents an interior view of the E-NTPase/E-NTPDase in the functional state after oligomerization and assembly in the membrane.
###end p 31
###begin p 32
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phase I: Activation. </bold>
Phase I: Activation. Based on direct experimental evidence, suppose that in response to electrical stimuli, an increased phosphatidylinositol turnover leads to elevated intracellular phospholipid. This in turn could induce post-translational modification of the monomer subunits of E-NTPase/E-NTPDase in the intracellular milieu. Subsequently, the monomers are translocated to the membrane, depending on the tissue type(s) and functional requirement(s).
###end p 32
###begin p 33
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phase I: Activation. </bold>
Phase I: Activation. Proposed model for E-NTPase/E-NTPDase in a functional state after oligomerization and assembly in the membrane, functioning as a gated channel.
###end p 33
###begin p 34
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phase I: Activation. </bold>
Phase I: Activation. The oligomerized E-NTPase/E-NTPDase would probably possess hypothetical sensors acting to open/close the gates.
###end p 34
###begin p 35
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phase I: Activation. </bold>
Phase I: Activation. Interior view of E-NTPase/E-NTPDase in a functional state in the membrane.
###end p 35
###begin p 36
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 309 314 309 314 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NPPB </bold>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
Probable energy sources and other significant factors are as follows. The source of extracellular nucleotides could be spontaneous release from dead cells or exocytosis from live/damaged cells [20]. In ocular ciliary epithelial cells, ATP is released in hypotonic conditions, and this release is inhibited by NPPB (5-nitro-2-(3-phenyl propylamine benzoic acid), a potent inhibitor of CFTR (cystic fibrosis transmembrane receptor) and p-glycoprotein mediated ATP release [21]. On the other hand, the endogenous CD39 of oocytes transforms under hypertonic conditions to a conformation mediating ATP transport to the extracellular environment, either by exocytosis or by acting as an ion channel [22,23]. However, under what conditions (hyper-or hypotonic) might CD39 assume an extracellular nucleotide hydrolyzing activity; and under those conditions, can this property be coupled to ion influx? This question remains unanswered.
###end p 36
###begin p 37
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 303 310 <span type="species:ncbi:9031">chicken</span>
At normal physiological temperature in presence of divalent succinyl CoA, Con A mediates the oligomerization of E-NTPase monomers/dimers to form a holoenzyme with enhanced activity. Eosin iodoacetamide (EIAA), a fluorescein iodoacetamide that forms thioester bonds with cysteine at neutral pH, enhances chicken gizzard ecto-ATPase activity [24].
###end p 37
###begin p 38
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
There are ten conserved cysteine residues in E-NTPase (with additional cysteine residues in the N-terminal region that are known to mediate disulfide bond formation, essential in oligomerization). CD39, an ecto-Ca2+/Mg2+ apyrase that hydrolyses ATP and ADP [25], forms tetramers and might act as a bivalent cation channel. However, the precise mechanism and functional properties are not known at present. CD39 expression is associated with ATP release; it was speculated that ATP release (along with drugs) into the extracellular milieu is followed by the hydrolysis of the extracellular nucleotides by CD39 [26].
###end p 38
###begin p 39
###xml 139 142 <span type="species:ncbi:10116">rat</span>
Furthermore, native CD39 (ecto-ATP/Dase/ apyrase) forms tetramers upon oligomerization. Loss of either of the two transmembrane domains of rat CD39 ecto-ATP/Dase impairs enzyme activity. It has been suggested that the functional (holoenzyme) E-NTPase/E-NTPDase is a homotrimer in mammals.
###end p 39
###begin p 40
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Differences in enzyme activity among different species have been attributed to variations in the interaction among the monomers resulting in homotrimeric holoenzyme formation (66 kDa-ATPase) [27]. It seems clear that changes in the conformation of the E-NTPase/E-NTPDase could mediate changes in the channel transport function.
###end p 40
###begin title 41
###xml 12 14 12 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Phase II: Ca2+/Mg2+ Transport
###end title 41
###begin p 42
###xml 5 7 5 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 116 119 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 157 159 157 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 474 477 474 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
Fig. 5a, illustrates the possible utilization of the energy released from [NTP] o /[NDP] o hydrolysis (-7.3 kcal mol-1 or by formation of AMP, -10.9 kcal/mol-1) for opening the channel formed by the homo-oligomeric E-NTPase/E-NTPDase. This channel is postulated to open and close in response to energy availability (Fig. 5b). Fig. 6A, is an artist's impression of the three-dimensional configuration of the E-NTPase/E-NTPDase in vivo. Ca2+ might enter the cell and excess Mg2+ might leave by the influx and efflux mechanisms depicted in Fig 6b.
###end p 42
###begin p 43
###xml 12 14 12 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 0 31 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phase II: Ca<sup>2+</sup>/Mg<sup>2+ </sup>Transport. </bold>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 146 149 146 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">or </bold>
###xml 208 210 208 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
Phase II: Ca2+/Mg2+ Transport. (A) Free energy released from ATP hydrolysis by E-NTPase on the outer membrane surface would yield -7.3 kcal mol-1 or by formation of AMP by E-NTPDase would yield -10.9 kcal mol-1. (B) The energy is utilized for opening the channel formed by the E-NTPase/E-NTPDase, by altering the conformation of the sensors. This altered conformation has an inherent channel-opening effect; loss of the energy source causes the sensors to revert to the resting state, which corresponds to channel closing.
###end p 43
###begin p 44
###xml 12 14 12 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 0 31 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phase II: Ca<sup>2+</sup>/Mg<sup>2+ </sup>Transport. </bold>
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 160 163 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Phase II: Ca2+/Mg2+ Transport. (A) Three-dimensional impression of the E-NTPase/E-NTPDase in vivo. (B) It is possible that Ca2+ can enter the cell and excess Mg2+ can leave via the influx/efflux mechanisms depicted in the figure.
###end p 44
###begin p 45
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 241 244 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
The opening of the slow inward Ca2+ current channel in cardiac sarcolemma during the plateau phase of the action potential requires ATP [28]. Furthermore, protein kinase-A (PKA) dependent phosphorylation appears to mediate the increase in Ca2+ influx in hormonal modulation of that process [29]. A similar model has been proposed for sodium channels in nerve membranes, in which a cycle of phosphorylation and dephosphorylation is proposed for opening and closing [30].
###end p 45
###begin p 46
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 439 442 439 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 454 457 454 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 597 600 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 118 121 <span type="species:ncbi:10116">Rat</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
Other corroborating evidence implicating E-NTPase in Ca2+/Mg2+ transport via the gated channel is briefly summarised. Rat cardiac sarcolemmal E-NTPase has considerable sequence homology with the human platelet thrombospondin receptor CD36 [31]. An antibody directed against the purified E-NTPase blocked the increase in intracellular calcium concentration, implying that the E-NTPase plays an unknown but significant role in the delayed Ca2+ influx or Mg2+ efflux during the plateau phase of the action potential (Unpublished observation). Activation of E-NTPase by millimolar concentrations of Ca2+ and electrical stimulation is linearly related to the contractile force developed in the myocardium [32]. Gramicidin S inhibits the E-NTPase activity and it attenuates the slow channel efflux in perfused frog left ventricles.
###end p 46
###begin p 47
###xml 98 100 98 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Based on these observations, we propose that E-NTPase might be involved in providing energy for Ca2+/Mg2+ influx-efflux in the cardiac sarcolemma, opening the channel formed by the E-NTPase/E-NTPDase protein by altering the conformation of the sensors. The altered channel sensor conformation opens the channel; loss of the energy source allows the sensors to revert to the resting state, which corresponds to channel closing.
###end p 47
###begin p 48
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 259 261 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 446 449 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 536 538 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 175 178 <span type="species:ncbi:10116">rat</span>
###xml 461 464 <span type="species:ncbi:10116">rat</span>
There are at least two Mg2+ transport systems: (a) rapid transport down the concentration gradient and (b) efflux in low Ca2+ Ringer during ventricular perfusion in vitro. In rat liver mitochondria, 50 nM cAMP or 250 muM ADP induced rapid loss of 6 mmol of Mg2+/mg protein coupled with the stimulation of ATP efflux. This effect was specific and was blocked by adenosine nucleotide translocase inhibitors. Evidently cAMP acts as a mobilizer of Mg2+ in isolated rat liver mitochondria. Adenine nucleotide translocase is the cAMP target [33].
###end p 48
###begin p 49
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 168 170 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 171 173 171 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 212 214 212 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 215 217 215 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 280 283 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7 </sup>
###xml 287 289 287 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 370 372 370 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 373 374 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
Myocardial Mg2+ content is maintained at physiological level by the sarcolemmal transport system, which pumps Mg2+ across the plasma membrane when the extracellular [Mg2+]o concentration is <1 mM and restores [Mg2+]i when the heart is perfused with Ringer buffer containing 5 x 10-7 M Mg2+. Failure of either of these two transport mechanisms may result in a rise in [Mg2+]i, impairing the contractile machinery of the myocardium [34].
###end p 49
###begin p 50
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 88 91 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 176 178 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
Gramicidin S inhibits total Mg2+ efflux in the myocardium, while epinephrine restores Mg2+ efflux and contractile force development in the frog ventricle perfused with 10 mM Mg2+. It should be pointed out that both E-NTPase activity and myocardial contraction and relaxation are inhibited by gramicidin S [35].
###end p 50
###begin p 51
###xml 127 130 127 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
In the light of the evidence surveyed here, there would appear to be a significant functional role for activated E-NTPase in Ca2+ influx and Mg2+ efflux (or vice versa) in the myocardium.
###end p 51
###begin title 52
Phase III: Termination of the transport process
###end title 52
###begin p 53
###xml 5 6 5 6 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
Fig. 7 summarizes the possible means by which the transport process is terminated. There are several potential contributing factors that can be grouped into two categories, extracelluar and intracellular. Additional experimental evidence is indicated. Based on the heterologous expression of ecto-apyrase in COS cells in the presence of tunicamycin, glycosylation might be required for homo-oligomerization and nuclotidase activity. Conversely, deglycosylation might impair the E-type nucleotidase activity by weakening the monomer-monomer interaction and altering the tertiary and quaternary structures, result in the loss of holoenzyme. Essentially, glycosylation and deglycosylation of the ecto apyrase (HB6) monomer and the consequences for homodimer formation have been regarded as an on-off switch for ecto nucleotidase activity [36].
###end p 53
###begin p 54
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phase III: Termination of the transport processes. </bold>
###xml 112 114 112 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Phase III: Termination of the transport processes. (A) Several factors might contribute to the termination of Ca2+/Mg2+ transport via channel gating by E-NTPase/E-NTPDase: extracelluar and Intracellular. Additional experimental evidence is mentioned. Decreased flow of Ca2+/Mg2+ due to closing of the channel gate.
###end p 54
###begin p 55
###xml 5 7 5 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8a</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8b</xref>
###xml 379 382 379 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 395 398 395 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
Fig. 8a is a three-dimensional impression of the ecto-ATPase in vivo at the termination of ion transport. Fig. 8b illustrates how biochemical modifications such as deglycosylation of the E-NTPase/E-NTPDase oligomers might cause dissociation of the homo-oligomers to individual monomers This is a potential mechanism for the disassembly of the functional channel and closure of Ca2+ influx and Mg2+ efflux. Also, an increase in membrane fluidity induced by cholesterol oxidation might cause defective association or disassociation due to weak interaction among the E-NTPase monomers, whereas increased membrane cholesterol might sustain higher E-NTPase activity. Oligomerization of E-NTPase and associated increase of activity could also be responsible for the rapid termination of the purinergic response mediated by extracellular ATP [37].
###end p 55
###begin p 56
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phase III: Termination of the transport processes. </bold>
###xml 413 416 413 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 429 432 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Phase III: Termination of the transport processes. (A) Three-dimensional impression of the E-NTPase/E-NTPDase in vivo when termination of the ion transport function commences. (B) Biochemical modifications of the E-NTPase/E-NTPDase oligomers such as deglycosylation would probably cause instability, leading to dissociation of the homo-oligomers. Disassembly of the functional molecule would ensue, closing the Ca2+ influx and Mg2+ efflux processes, as portrayed in the figure.
###end p 56
###begin p 57
###xml 388 390 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
The extracellular nucleotide mediated activation of channel gating could be terminated by ecto (extracellular)-adenylate kinase, which catalyzes trans-phosphorylase activity (ADP+ADP--> ATP+AMP). This enzyme has a higher affinity for extracellular nucleotides than the dephosphorylating enzyme (E-NTPase/E-NTPDase) or ecto-nucleotide pyrophosphatase/phospho-diesterase (ATP--> AMP +ppi) [38].
###end p 57
###begin p 58
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
As the transport process winds down, ecto-adenylate kinase mediated ATP generation might maintain the extracellular nucleotide level. However, the precise biochemical kinetic process by which this process is completed remains to be elucidated [39].
###end p 58
###begin title 59
###xml 66 68 66 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Pathophysiological Significance of E-type nucleotidase mediated Ca2+/Mg2+ transport
###end title 59
###begin p 60
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 253 255 253 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 258 260 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 67 70 <span type="species:ncbi:10116">rat</span>
###xml 239 242 <span type="species:ncbi:10116">rat</span>
Impairment of E-Type nucleotidases during Ca2+ paradox in isolated rat heart model warrants investigation of the molecular mechanism(s) involved. Knowledge obtained from these studies will elucidate the observed protective effects of anti-rat cardiac Ca2+/Mg2+-ecto-ATPase antibodies in ischemia reperfusion induced damage, which is a corollary of organ transplantation. Furthermore, the antiproliferative effect(s) of these antibodies in left anterior descending coronary artery smooth muscle cell(s) emphasize the need to explore more fully the hypothesis proposed in this article.
###end p 60
###begin title 61
Authors' contributions
###end title 61
###begin p 62
HMS participated and provided the hypothetical scheme of the gating mechanism with appropriate literature. SK conceived and carried out experimental part of the investigation and formulating the hypotheses.
###end p 62
###begin title 63
Abbreviations
###end title 63
###begin p 64
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E-NTPase </bold>
###xml 60 70 60 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E-NTPDase </bold>
###xml 141 143 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 144 146 144 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 138 146 138 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink">[Ca<sup>2+</sup>]<sub>i </sub></bold>
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 173 175 173 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0 </sub>
###xml 168 175 168 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">[NTP]<sub>0 </sub></bold>
###xml 216 221 216 221 <bold xmlns:xlink="http://www.w3.org/1999/xlink">[NDP]</bold>
###xml 221 223 221 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0 </sub>
###xml 263 268 263 268 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ROCC </bold>
###xml 290 293 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 302 306 302 306 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SER </bold>
###xml 346 348 346 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 340 348 340 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">[cAMP]<sub>i </sub></bold>
###xml 385 390 385 390 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PMCA </bold>
###xml 410 412 410 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 424 429 424 429 <bold xmlns:xlink="http://www.w3.org/1999/xlink">VOCC </bold>
###xml 450 453 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 462 468 462 468 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LGCCS </bold>
###xml 513 520 513 520 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RACC = </bold>
###xml 562 564 562 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 574 578 574 578 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SUR </bold>
###xml 612 617 612 617 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD36 </bold>
###xml 657 662 657 662 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD39 </bold>
###xml 671 673 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 676 678 676 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
E-NTPase = Ecto or Extracellular Nucleotide triphosphatase; E-NTPDase = Ecto or Extracellular Nucleotide triphosphate diphosphohydrolase; [Ca2+]i = Intracellular Ca2+; [NTP]0 = Extracellular Nucleotide triphosphate; [NDP]0 = Extracellular Nucleotide diphosphate; ROCC = Receptor Operated Ca2+ channel; SER = Sarco (Endo) plasmic reticulum; [cAMP]i = Cytoplasmic or intracellular cAMP; PMCA = Plasma membrane Ca2+pump ATPase.VOCC = voltage-operated Ca2+ channel; LGCCS = Ligand gated non-specific cation channels. RACC = Stretch/Receptor activated non-specific Ca2+channels. SUR = Sulfonylurea Receptor Proteins. CD36 = Thrombospondin receptor on platelets. CD39 = Ecto Ca2+/Mg2+apyrase.
###end p 64
###begin title 65
Acknowledgements
###end title 65
###begin p 66
Data were obtained during graduate (Ph.D.) work (1993-1998) supported by a graduate fellowship (to S.K) from St. Boniface General Hospital Research Foundation, Winnipeg, Canada. T.R. Smith, Medicinal Chemistry, University of Warwick, Leamington Spa, and Warwickshire, United Kingdom prepared most of the models. This manuscript was prepared during the tenure of a post-doctoral fellowship (September 2000 - January 2001) supported by grants DK-52216 and DK-44237 from the National Institutes of Health, Bethesda, MD, and USA. T.L. Kirley, A.F. Knowles, L. Plesner, A.R. Beaudoin, A.Z. Herzberg, M. Handa, K.A. Jacobson, A. Froese, P. Zahradka, L.J. Murphy, N.N. Tandon, N. Abumrad, A. Ibrahimi, R. Lipsky, D. Perlmutter, S.H. Lin, H. Zimmermann and N.N. Tandon are acknowledged for donating reagents, advises, and expert opinion on investigation during the period 1991-1998. Dr. Hans M. Schreiber has passed away during the preparation of this manuscript.
###end p 66
###begin p 67
The authors do not have any competing financial or intellectual properties interests with CIBA-GEIGY Canada or Novartis Pharmaceuticals Inc, Switzerland. Modified reagents are part of the impending U.S. or International patent application(s).
###end p 67
###begin article-title 68
Structure and function of voltage-gated ion channels
###end article-title 68
###begin article-title 69
Exocytotic Ca2+ channels in mammalian central neurons
###end article-title 69
###begin article-title 70
Neuronal excitability: voltage-dependent currents and synaptic transmission
###end article-title 70
###begin article-title 71
Calcium signaling
###end article-title 71
###begin article-title 72
Elementary and global aspects of calcium signalling
###end article-title 72
###begin article-title 73
The inositol phosphate-calcium signaling system in nonexcitable cells
###end article-title 73
###begin article-title 74
###xml 92 95 <span type="species:ncbi:10116">rat</span>
Rapid Ca2+ influx induced by the action of dibutylhydroquinone and glucagon in the perfused rat liver
###end article-title 74
###begin article-title 75
###xml 111 114 <span type="species:ncbi:10116">rat</span>
Distinct functions of Gq and G11 proteins in coupling alpha1-adrenoreceptors to Ca2+ release and Ca2+ entry in rat portal vein myocytes
###end article-title 75
###begin article-title 76
Nucleotides and cd39: principal modulatory players in hemostasis and thrombosis
###end article-title 76
###begin article-title 77
Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition
###end article-title 77
###begin article-title 78
ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes
###end article-title 78
###begin article-title 79
Ecto-ATPases in protozoa parasites: looking for a function
###end article-title 79
###begin article-title 80
E-NTPase /E-NTPDase: a potential regulatory role in E-kinase/PKA-mediated CD36 activation
###end article-title 80
###begin article-title 81
Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases
###end article-title 81
###begin article-title 82
Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection
###end article-title 82
###begin article-title 83
###xml 73 76 <span type="species:ncbi:10116">rat</span>
Calcium-linked changes in myocardial metabolism in the isolated perfused rat heart
###end article-title 83
###begin article-title 84
Calcium movements in relation to heart function
###end article-title 84
###begin article-title 85
###xml 96 99 <span type="species:ncbi:10116">rat</span>
Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart
###end article-title 85
###begin article-title 86
Modification of heart sarcolemmal Na+/K+-ATPase activity during development of the calcium paradox
###end article-title 86
###begin article-title 87
Extracellular ATP: effects, sources and fate
###end article-title 87
###begin article-title 88
A release mechanism for stored ATP in ocular ciliary epithelial cells
###end article-title 88
###begin article-title 89
###xml 50 57 <span type="species:ncbi:8355">Xenopus</span>
Release of ATP induced by hypertonic solutions in Xenopus oocytes
###end article-title 89
###begin article-title 90
ATP crossing the cell plasma membrane generates an ionic current in xenopus oocytes
###end article-title 90
###begin article-title 91
###xml 14 21 <span type="species:ncbi:9031">chicken</span>
Regulation of chicken gizzard ecto-ATPase activity by modulators that affect its oligomerization status
###end article-title 91
###begin article-title 92
The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structure
###end article-title 92
###begin article-title 93
Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis
###end article-title 93
###begin article-title 94
Control of cell membrane ecto-ATPase by oligomerization state: intermolecular cross-linking modulates ATPase activity
###end article-title 94
###begin article-title 95
A metabolic control mechanism for calcium ion influx that may protect the ventricular myocardial cell
###end article-title 95
###begin article-title 96
Activation of heart sarcolemmal Ca2+/Mg2+ ATPase by cyclic AMP-dependent protein kinase
###end article-title 96
###begin article-title 97
Protein phosphorylation and sodium conductance in nerve membrane
###end article-title 97
###begin article-title 98
###xml 21 24 <span type="species:ncbi:10116">rat</span>
Molecular cloning of rat cardiac sarcolemmal Ca2+/Mg2+ ectoATPase (Myoglein)
###end article-title 98
###begin article-title 99
Activation of Ca2+/Mg2+ ATPase in heart sarcolemma upon electrical stimulation
###end article-title 99
###begin article-title 100
Myocardial magnesium transport: effect of gramicidin S and epinephrine
###end article-title 100
###begin article-title 101
###xml 37 40 <span type="species:ncbi:10116">rat</span>
Cyclic AMP-induced Mg2+ release from rat liver hepatocytes, permeabilized hepatocytes, and isolated mitochondria
###end article-title 101
###begin article-title 102
Calcium dependent magnesium uptake in myocardium
###end article-title 102
###begin article-title 103
###xml 20 23 <span type="species:ncbi:10116">rat</span>
Characterization of rat heart plasma membrane Ca2+/Mg2+ ATPase
###end article-title 103
###begin article-title 104
###xml 58 63 <span type="species:ncbi:9606">human</span>
Glycosylation is essential for functional expression of a human brain ecto-apyrase
###end article-title 104
###begin article-title 105
Control of cell membrane ecto-ATPase by oligomerization state: intermolecular cross-linking modulates ATPase activity
###end article-title 105
###begin article-title 106
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human airway ecto-adenylate kinase. A mechanism to propagate ATP signaling on airway surfaces
###end article-title 106

